ING Groep N.V. (0A2K)
London Exchange · UK · prices in USD · close of 15 Oct 2026
Key indicators
| Last close | USD 17.66 |
|---|---|
| 52-week range | 16.18 – 17.66 |
| Return, 1 month / 3 months | +0.0% / +2.7% |
| Return, 1 year / 3 years | +9.2% / +73.8% |
| Trend | Uptrend |
| RSI (14) | 100 |
| Volatility (1 year) | 5.7% |
| Worst drawdown (1 year) | 0.0% |
| Average daily value traded | 0.00M USD |
| Dividend yield | 8.6% |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
ING Groep is a banking and financial services group based in the Netherlands. It provides retail banking such as current accounts, savings, mortgages, personal loans and payments to individual customers, and offers business and wholesale banking, lending, trade finance and treasury services to companies and institutions. It also provides insurance and asset management services. Its customers are spread across European countries and other markets in Asia and the Americas, served largely through digital channels and branch networks.
The shares are listed on the London Exchange in UK under the code 0A2K, and the price on this page is in US dollars (USD). Our dividend records, which start in 2019, show payments in 6 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
ING Groep N.V. (0A2K) trades on the London Exchange in UK. It last closed at USD 17.66 on 15 October 2026.
Its price-based Market X-Ray is 65 out of 100 (a fair price profile), ranking 950 of 3,787 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price rose 9.2% and over the last three months it rose 2.7%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on London Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 73 · Strong | Trading above its long-term averages and near its highs. | |
| Above 200-day average | 3.9% | ||
| From 52-week high | 0.0% | ||
| Momentum | 58 · Fair | Typical recent returns for this exchange. | |
| 3-month return | 2.7% | ||
| 6-month return | 2.7% | ||
| 12-month return, skipping the last month | 9.2% | ||
| Stability (higher is calmer) | 99 · Strong | Calmer than most: low volatility and shallow drawdowns. | |
| Volatility, 1 year (lower is calmer) | 5.7% | ||
| Worst drawdown, 1 year (smaller is calmer) | 0.0% | ||
| Liquidity | 1 · Weak | Thinly traded: prices can jump and exits can be hard. | |
| Average daily value traded | 0.00M USD | ||
| Zero-volume days | 100.0% | ||
| Income | 68 · Fair | Dividend is typical for this exchange. | |
| Dividend yield | 8.6% | ||
| Years with dividends | 5 |
Strengths
- Trend: Trading above its long-term averages and near its highs.
- Stability (higher is calmer): Calmer than most: low volatility and shallow drawdowns.
Weak spots
- Liquidity: Thinly traded: prices can jump and exits can be hard.
Returns
| 1 week | +0.0% |
|---|---|
| 1 month | +0.0% |
| 3 months | +2.7% |
| 6 months | +2.7% |
| 1 year | +9.2% |
| 3 years | +73.8% |
| 5 years | +73.7% |
Signals
| 50-day / 200-day average | 17.64 / 17.00 |
|---|---|
| Golden / death cross (60 days) | None |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 0.00 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 10 Aug 2026 | EUR 0.4611 |
| 17 Apr 2026 | EUR 0.8606 |
| 8 Jan 2026 | EUR 0.1996 |
| 11 Aug 2025 | EUR 0.4051 |
| 25 Apr 2025 | EUR 0.8019 |
| 10 Jan 2025 | EUR 0.1651 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on London Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.